Strategic Issue: Patients diagnosed with Atrial Fibrillation (AFib) are challenged in managing their condition by 1) Desperate data from from wearables and 2) A lack of education and information about their condition and how to be empowered to manage it themselves.

​

Strategic Goal: Create an easy to use resource to empower the AFib patient to take back control in their heart health journey.

​

Strategy: AFibLife mobile app:

• Develop easy to use dashboard which integrates and overlays all app data in one place.

• Centralize education from Abbott EP patient resources.

• Integrate our proprietary clinical survey on the AFib' s effect on quality of life (AFEQT.com) so patients can, for the first time have direct access to it.

• Provide a patient facing web resource to learn about the app and commercialize D2C.

• Create a place for the patient to take notes and track their day-to-day experiences which can later be share with their doctor.

• Apple and Google health kit data integration.

​

Results: We developed the first, direct to consumer mobile app AFibLife.com with subscription functionality in the Medical Device division. With our initial launch in may 2023, we created a seamless user experience which puts the patient in the driver seat and not the medical device. We integrated Apple Health kit, AFEQT questionnaire, EP patient education, patient Journaling and a subscription model to monetize the Abbott IP. By the end of 2023, additional roll out will be compete to Japan, India, Germany, UK, and Brazil. New features will also include:

• CHAD Vas stroke risk calculator

• 2 factor security integration

• medication tracking

• Kardia data integration

• Trendline data export.